- Medicine - Sep 23 Novartis receives three new FDA approvals for the expanded use of Ilaris treating rare Periodic Fever Syndrome conditions
- Life Sciences - Sep 23 How natural selection acted on one penguin species over the past quarter century
- Life Sciences - Sep 23 Biologist receives the Ig Nobel Prize
- Medicine - Sep 23 Novartis announces positive top- line results from ASCEND-4, a Phase III trial of Zykadia in untreated adult ALK+ NSCLC patients
- Life Sciences - Sep 23 How to power up graphene implants without frying cells
- Medicine - Sep 23 National Eye Health Week – Grant success for unique stem cell therapy
- Environment - Sep 22 Fate of turtles and tortoises affected more by habitat than temperature
- Life Sciences - Sep 22 Gaps in data place thousands of illegally traded wild animals at risk, say researchers
- Medicine - Sep 22 Plant- made Antimicrobial Peptide Targets Dental Plaque and Gum Tissues
- Life Sciences - Sep 22 Five young Yale scientists recognized for excellence
- Medicine - Sep 22 5 UW professors among HHMI’s inaugural class of Faculty Scholars
- Medicine - Sep 22 Two named Howard Hughes Medical Institute scholars
- Life Sciences - Sep 22 To produce biopharmaceuticals on demand, just add water
- Life Sciences - Sep 22 Melatonin, biological clock keep singing fish on time
- Life Sciences - Sep 22 Unique feeding habits of whales come to light
- Medicine - Sep 22 Fish stress if they can’t socialise
Brain cells created from patients’ skin cells
This approach gives us the ability to study human brain development and disease in ways that were unimaginable even five years ago."—Dr Rick Livesey of the Gurdon Institute and Department of Biochemistry at the University of Cambridge
Cambridge scientists have, for the first time, created cerebral cortex cells - those that make up the brain’s grey matter – from a small sample of human skin. The researchers’ findings, which were funded by Alzheimer’s Research UK and the Wellcome Trust, were published today .
Diseases of the cerebral cortex range from developmental conditions, such as epilepsy and autism, to neurodegenerative conditions such as Alzheimer’s. Today’s findings will enable scientists to study how the human cerebral cortex develops, how it ’wires up’ and how that can go wrong (a common problem leading to learning disabilities).
It will also allow them to recreate brain diseases, such as Alzheimer’s, in the lab. This will give them previously impossible insight, allowing them to both watch the diseases develop in real time and also develop and test new drugs to stop the diseases progressing.
Rick Livesey of the Gurdon Institute and Department of Biochemistry at the University of Cambridge, principal investigator of the research, said: " This approach gives us the ability to study human brain development and disease in ways that were unimaginable even five years ago."
For their research, the scientists took skin biopsies from patients and then reprogrammed the cells from the skin samples back into stem cells. These stem cells as well as human embryonic stem cells were then used to generate cerebral cortex cells.
Livesey added: " We are using this system to recreate Alzheimer’s disease in the lab. Alzheimer’s disease is the commonest form of dementia in the world, and dementia currently affects over 800,000 people in the UK. It’s a disease that primarily affects the type of nerve cell we’ve made in the lab, so we’ve the perfect tool to create a full, human model of the disease in the lab."
Simon Ridley, Head of Research at Alzheimer’s Research UK, the UK’s leading dementia research charity, said:
"We are really pleased to have contributed funding for this work and the results are a positive step forward. Turning stem cells into networks of fully functional nerve cells in the lab holds great promise for unravelling complex brain diseases such as Alzheimer’s.
"Dementia is the greatest medical challenge of our time – we urgently need to understand more about the condition and how to stop it. We hope these findings can move us closer towards this goal."
Last job offers
- Medicine/Pharmacology - 15.9
Leiter/in Forschung & Entwicklung Pflege (Professorenstelle)
- Medicine/Pharmacology - 15.9
Leiter/in des Studiengangs Master of Science in Pflege
- Life Sciences - 14.9
Einstieg für Naturwissenschaftler / Biologen in die IT-Consulting Welt
- Life Sciences - 11.9
Postdoctoral Research Fellowship
- Environment - 9.9
Leiter/in der Forschungsgruppe Vegetationsökologie
- Medicine/Pharmacology - 7.9
Software Systems Requirements Engineer - Medical Device
- Medicine/Pharmacology - 22.9
Associate professor in forensic medicine (combined position)
- Life Sciences - 22.9
Researcher in Biology PA 2016/3439